Hui-Deng Long

机构：Nantong University, Ruijin Hospital, Taizhou People's Hospital · ORCID：0000-0002-5538-2304

发表论文 10 篇 · 总被引 208 次 · h-index 6

代表论文

• miR-30 Family Reduction Maintains Self-Renewal and Promotes Tumorigenesis in NSCLC-Initiating Cells by Targeting Oncogene TM4SF1 (2018 · Molecular Therapy · 被引 54)
• Reduced hsa-miR-124-3p levels are associated with the poor survival of patients with hepatocellular carcinoma (2018 · Molecular Biology Reports · 被引 49)
• Inhibition of USP14 Deubiquitinating Activity as a Potential Therapy for Tumors with p53 Deficiency (2020 · Molecular Therapy — Oncolytics · 被引 35)
• Expression and potential prognostic value of histone family gene signature in breast cancer (2019 · Experimental and Therapeutic Medicine · 被引 30)
• Dual Regulatory Mechanisms of Expression and Mutation Involving Metabolism-Related Genes FDFT1 and UQCR5 during CLM (2019 · Molecular Therapy — Oncolytics · 被引 22)
• The expression and clinical significance of secretory leukocyte proteinase inhibitor (SLPI) in mammary carcinoma using bioinformatics analysis (2019 · Gene · 被引 9)